News

Johnson and Johnson beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as ...
"Other trading partners observing these threats will have the same mistrust of the negotiation process," experts argue.
President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...
Four months since Trump fired the opening salvo of his trade war, only China and Canada have dared to hit back at Washington ...
The president’s much-awaited “big announcement” gave Vladimir Putin another dangerous pass as Russia continues its summer ...
The EU and Mexico collectively comprise around one-third of U.S. imports by value, and the U.S. is a critical export market ...
Russian President Vladimir Putin has sacrificed an estimated 1 million of his soldiers, killed and wounded, in a three-year ...
The Trump administration and many market observers are offering diametrically opposed explanations for why dramatic tariff ...
Zacks Investment Research on MSN6hOpinion
5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats
The uncertainty around tariffs and trade production measures has muted economic growth. President Trump has once again ...
After posting a double beat for Q2 2025, J&J (NYSE:JNJ), the pharma sector’s bellwether for the earnings season, added ~6% on ...
President Trump’s approach to setting tariff rates is causing anxiety in the business community, with the trickling flow of letters to trad​e partners exacerbating concerns over hits to the ...
The two countries are the largest purchasers of Russian oil. Read more at straitstimes.com. Read more at straitstimes.com.